InGeneron launches new stem cell clinical trial

InGeneron is looking to see how effective the utilisation of regenerative cells from a patient can be in healing a knee cartilage.

One of the world's most innovative developers of cell-based technologies for healthcare and veterinary medicine has announced that it is to deliver a clinical trial to gauge the effectiveness of "adult adipose derived regenerative cells" in boosting how the cartilage heals after knee surgery.

InGeneron's study will make use of its Transpose RTTM system, which will extract regenerative cells from a patient's own fat tissue.

It is hoped that the experiment will produce some interesting results, as more than four million knee minor-knee operations – known as arthroscopies – are carried out all over the world every year.

Dr Robert Burke, lead author of the study and an orthopaedic surgeon with Fondren Orthopaedic Group in Houston Texas, is confident that this study will confirm his belief that stem cells from a person's own fat will boost cartilage healing.

"Articular cartilage the smooth surface covering the joints at the ends of bones has no good way of healing on its own," Dr Burke said. "The body doesn’t create enough new cartilage of the same type to repair the damage.

"Stem cells and other regenerative cells that we can obtain from fat have the potential to do that."